Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KING: 18F-FDOPA PET Kinetics in Non-contrast Enhanced Gliomas
NCT05512403Phase 3Recruiting
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Jun 2023
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial, sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Diagnostic performances of 18F-FDOPA PET Time-To-Peak at 24 months. Started Jun 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05512403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05512403.